Calithera Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Calithera Biosciences

07/05/2021 10:38

* Calithera Biosciences Inc  CALA.OQ  reported a quarterly
adjusted loss of 28 cents​​ per share for the quarter ended
in March. The mean expectation of six analysts for the quarter
was for a loss of 28 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* Calithera Biosciences Inc's reported EPS for the quarter was a
loss of 28 cents​.
* The mean earnings estimate of analysts had risen by about 4.1%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Calithera Biosciences Inc shares had fallen by 14.0% this
quarter and lost 57.6% so far this year.
* The company reported a quarterly loss of $20.4 million.
* Wall Street's median 12-month price target for Calithera
Biosciences Inc is $4.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 7 at 09:38 a.m. GMT. ​All
figures in US Dollars.​